Publications by authors named "Nadia Garman"

Claim this Profile
C
Clinical quantification of the integrin αvβ6 by [F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study).
Pauline T Lukey, Christopher Coello, Roger Gunn, Christine Parker, Frederick J Wilson, Nadia Garman

Eur J Nucl Med Mol Imaging· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of F-FB-A20FMDV2 for Imaging the Integrin αβ.
Nicholas Keat, Julia Kenny, Keguan Chen, Mayca Onega, Nadia Garman

J Nucl Med Technol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants.
Charlotte H Maden, David Fairman, Michelle Chalker, Maria J Costa, William A Fahy, Nadia Garman

Eur J Clin Pharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID.
Heide Stirnadel-Farrant, Mahesh Kudari, Nadia Garman, Jessica Imrie, Bikramjit Chopra

Orphanet J Rare Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Series: Pragmatic trials and real world evidence: Paper 7. Safety, quality and monitoring.
Elaine Irving, Rutger van den Bor, Paco Welsing, Veronica Walsh, Rafael Alfonso-Cristancho, Nadia Garman

J Clin Epidemiol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis